
Sep 2024: Neurode raised a US$3.5M (A$5.2M) pre-seed led by Khosla Ventures with PsyMed Ventures. The funding supports clinical trials of the Neurode Wave, an at-home ADHD headband that combines prefrontal electrical stimulation with light-based brain sensing. It is not yet cleared by the FDA or Australia’s TGA.